Dott Gallino Gianfrancesco

Doctor

Contacts

Mail: Gianfranco.gallino@istitutotumori.mi.it
Tel: 02 23902204

Specialty / Department

Surgery

1994: Graduated in Medicine and Surgery with honors and a published thesis from the University of Milan.

1999: Specialized in General Surgery with a published thesis and honors from the University of Milan.

1999: Winner of the Young Researchers Award from the Italian Society of Surgical Oncology of Milan for an original publication.

August 2000 - September 2012: Hired as a permanent Medical Executive at the Colorectal Surgery Unit of the IRCCS INT Foundation in Milan, where I worked for 12 years.

2005: Winner of the annual award for the best scientific research among under 40s (Young Researchers Award) issued by the IRCCS INT Foundation in Milan.

2006-2011: Awarded four scholarships for original scientific works concerning colorectal oncologic surgery, melanoma treatment, surgery for anal melanomas, and fertility preservation after major surgery.

 2000-2010: Member of the scientific committee for 4 editions of the International Symposium of Rectal Surgery and lecturer for the annual Master in Colorectal Surgery.

 September 2012 - Present: Medical Executive at the Melanoma and Sarcoma Unit, IRCCS INT Milan.

 Participated in three editions (2013, 2015, 2017) of the advanced ESSO course on clinical management of cutaneous melanoma and served as a speaker at numerous conferences on topics related to melanomas and other skin neoplasms.

 Areas of particular interest have always been the surgical treatment of advanced melanoma and the early diagnosis of melanoma recurrences through the analysis of biomolecular markers (cell-free DNA and miRNA).

Outcome evaluation of patients with melanoma and positive sentinel node after MSLT-II and DeCOG trials and the advent of adjuvant therapies. (Melanoma_SN+);

Evaluation of local recurrence risk in patients with melanoma in situ not undergoing wide radical excision after diagnostic excision. cite_start

   * Phase III multicenter, randomized, open-label study of the efficacy of neoadjuvant intratumoral treatment with L19IL2/L19TNF followed by surgery, versus surgery alone in patients with clinical stage IIIB/C melanoma. cite_start

   * Activation of the immune system following electrochemotherapy treatment: prospective evaluation.

PUBB Gallino.pdf

Board elegibility (Italy), residency training and speciality diploma in General Surgery at the University of Milan